{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:45:58Z","timestamp":1792010758856,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2025ZYGXZR105"],"award-info":[{"award-number":["2025ZYGXZR105"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515220097"],"award-info":[{"award-number":["2023A1515220097"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010653"],"award-info":[{"award-number":["2024A1515010653"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515220183"],"award-info":[{"award-number":["2021A1515220183"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272103"],"award-info":[{"award-number":["82272103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.imlet.2026.107246","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:37Z","timestamp":1790780917000},"page":"107246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stromal spatial signatures of the classical adenosine pathway dictate prognosis in hepatocellular carcinoma"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5974-8919","authenticated-orcid":false,"given":"Yao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imlet.2026.107246_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10360","key":"10.1016\/j.imlet.2026.107246_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.02.016","article-title":"The role of molecular enrichment on future therapies in hepatocellular carcinoma","volume":"69","author":"Nault","year":"2018","journal-title":"J. Hepatol."},{"issue":"20","key":"10.1016\/j.imlet.2026.107246_bib0004","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.imlet.2026.107246_bib0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107246_bib0007","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.imlet.2026.107246_bib0008","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gutjnl-2018-316510","article-title":"Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Lim","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.imlet.2026.107246_bib0009","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gutjnl-2014-307990","article-title":"Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches","volume":"64","author":"Greten","year":"2015","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.imlet.2026.107246_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.imlet.2026.107246_bib0011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.imlet.2026.107246_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends. Mol. Med."},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunol. Rev."},{"issue":"35","key":"10.1016\/j.imlet.2026.107246_bib0014","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-018-0360-8","article-title":"Targeting adenosine for cancer immunotherapy","volume":"6","author":"Leone","year":"2018","journal-title":"J. ImmunOther Cancer"},{"issue":"12","key":"10.1016\/j.imlet.2026.107246_bib0016","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2026.107246_bib0017","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.imlet.2026.107246_bib0018","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.5474","article-title":"Three-dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding","volume":"251","author":"Yoshizawa","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0019","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-019-0724-7","article-title":"CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K\/AKT signaling by inducing Rap1-mediated membrane localization of P110\u03b2 and predicts poor prognosis","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107246_bib0020","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1152\/physrev.00028.2017","article-title":"The BMP pathway and its inhibitors in the skeleton","volume":"98","author":"Lowery","year":"2018","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.imlet.2026.107246_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2026.107246_bib0022","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.bcp.2005.09.006","article-title":"Role of the carboxy-terminal transactivation domain and active transcription in the ligand-induced and ligand-independent degradation of the mouse ahb-1 receptor","volume":"70","author":"Pollenz","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.imlet.2026.107246_bib0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molmed.2013.04.002","article-title":"The remarkable conformational plasticity of alpha-synuclein: blessing or curse?","volume":"19","author":"Deleersnijder","year":"2013","journal-title":"Trends. Mol. Med."},{"key":"10.1016\/j.imlet.2026.107246_bib0024","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.imlet.2026.107246_bib0025","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1096\/fj.06-6419com","article-title":"HIF-dependent induction of adenosine A2B receptor in hypoxia","volume":"20","author":"Kong","year":"2006","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.imlet.2026.107246_bib0026","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.4049\/jimmunol.1101633","article-title":"Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls","volume":"187","author":"Verkoczy","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107246_bib0027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4049\/jimmunol.1102214","article-title":"TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation","volume":"188","author":"Wagner","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2026.107246_bib0028","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/j.coph.2020.08.001","article-title":"Withdrawal notice to: adult hippocampal neurogenesis and antidepressants effects [COPHAR, 50 2020, 17-24]","volume":"50","author":"Planchez","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.imlet.2026.107246_bib0029","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2026.107246_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2025.1669236","article-title":"Spatial heterogeneity reveals an evolutionary signature predicting therapeutic response and clinical outcomes in hepatocellular carcinoma","volume":"5","author":"Luo","year":"2025","journal-title":"Front. Bioinform."},{"issue":"1","key":"10.1016\/j.imlet.2026.107246_bib0031","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41698-024-00752-1","article-title":"Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma","volume":"8","author":"Ye","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107246_bib0032","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s11684-024-1071-9","article-title":"Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma","volume":"18","author":"Zou","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.imlet.2026.107246_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115331","article-title":"Activation of basal forebrain cholinergic neurons improves colonic hyperpermeability through the vagus nerve and adenosine A2B receptors in rats","volume":"206","author":"Ishioh","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.imlet.2026.107246_bib0034","article-title":"Enhancing extracellular adenosine levels restores barrier function in acute lung injury through expression of focal adhesion proteins","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.imlet.2026.107246_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mucimm.2026.03.007","article-title":"CD39 regulates P2RX7-mediated lung necrotic lesions in severe experimental tuberculosis","volume":"19","author":"Almeida-Santos","year":"2026","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.imlet.2026.107246_bib0036","doi-asserted-by":"crossref","first-page":"0278","DOI":"10.34133\/bmr.0278","article-title":"Purinergic receptor nanoimmunoamplifiers potentiate chemoimmunotherapy efficacy in hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2025","journal-title":"Biomater. Res."},{"key":"10.1016\/j.imlet.2026.107246_bib0037","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mam.2017.01.002","article-title":"Extracellular ATP and adenosine: the yin and yang in immune responses?","volume":"55","author":"Faas","year":"2017","journal-title":"Mol. Aspects. Med."},{"issue":"6487","key":"10.1016\/j.imlet.2026.107246_bib0038","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science (1979)"},{"issue":"20","key":"10.1016\/j.imlet.2026.107246_bib0039","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","article-title":"Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs","volume":"19","author":"Allard","year":"2013","journal-title":"Clin. Cancer Res."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:29Z","timestamp":1792008089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":39,"alternative-id":["S0165247826001203"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107246","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stromal spatial signatures of the classical adenosine pathway dictate prognosis in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107246"}}